mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.1 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.079 |
0.1 |
mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |